Erythrocytes as carriers for drugs: The transition from the laboratory to the clinic is approaching

Expert Opinion on Biological Therapy

Volumn 12, Issue 2, 2012, Pages 137-138

  Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

Author keywords

Carrier erythrocytes; Drug delivery; Translational medicine

Indexed keywords

DRUG CARRIER;

DRUG DELIVERY SYSTEM; ERYTHROCYTE; EUROPE; INDUSTRIALIZATION; LABORATORY; MEDICAL RESEARCH; REVIEW; TECHNOLOGY;

ANIMALS; CLINICAL LABORATORY TECHNIQUES; DRUG CARRIERS; ERYTHROCYTES; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 84855690182     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2012.650163     Document Type: Review

References (9)

1. Ihler GM, Glew RH, Schnure FW. Enzyme loading of erythrocytes. Proc Natl Acad Sci USA 1973;70:2663-6
2. Biagiotti S, Paoletti MF, Fraternale A, et al. Drug delivery by red blood cells. IUBMB Life 2011;63:621-31
3. Muzykantov VR. Drug delivery by red blood cells: vascular carriers designed by mother nature. Expert Opin Drug Deliv 2010;7:403-27
4. Magnani M, Serafini S, Fraternale A, et al. Red blood cell-based delivery of drugs and nanomaterials for therapeutic and diagnostic applications. Encyclopedia Nanosci Nanotechnol 2011;22:309-54
5. Pierige F, Serafini S, Rossi L, Magnani M. Cell-based drug delivery. Adv Drug Deliv Rev 2008;60:286-95 (Pubitemid 350236405)
6. Murciano JC, Medinilla S, Eslin D, et al. Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes. Nat Biotechnol 2003;21:891-6 (Pubitemid 36936194)
7. Zaitsev S, Spitzer D, Murciano JC, et al. Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation. Blood 2010;115 (2):5241-8
8. Progressions. Building Pharma 3.0. Ernest & Young Global Pharmaceutical Industry report 2011. p. 1-75
9. Godfrin Y, Horand F, Franco R, et al. International seminar on the red blood cells as vehicles for drugs. Expert Opin Biol Ther 2012;12:127-33